The headlines have moved on. The panic has subsided. But in the labs of West Africa, funded by British taxpayers, a quieter drama is unfolding.
The numbers are down: new cases of Ebola have fallen sharply, a testament to the gritty, unglamorous work of contact tracing and community engagement. Yet the virus, as we have learned, does not respect our attention spans. Surveillance gaps remain.
The machinery of detection is not yet seamless. At a lab in Sierra Leone, a technician told me that the real battle is against complacency. 'The virus is still here,' she said, 'waiting for a moment of weakness.
' These UK-funded labs are more than scientific outposts. They are early warning systems. They employ local scientists, train local staff, and embed knowledge in communities.
When the next outbreak comes, and it will, this infrastructure could mean the difference between a containable flare-up and a global emergency. But funding is precarious. The political will, as ever, is fickle.
For now, we celebrate the falling numbers. But the real story is the quiet, persistent vigilance that keeps them low. The human cost of slackening that vigilance is not just measured in cases, but in lives uprooted, economies shattered, and trust broken.
We must not look away.
